Search Result "svr assay"
Recent Advances in Pegylated Interferon Antiviral Therapy of Chronic Hepatitis C
Journal: Anti-Infective Agents in Medicinal Chemistry
Volume: 5 Issue: 4 Year: 2006 Page: 379-387
Author(s): Carla S. Coffin, Samuel S. Lee
Predictability of Sustained Virological Response to Pegylated Interferon Alpha-2b Plus Ribavirin Therapy by Week-8 Viral Response in HIVPositive Patients with Chronic Hepatitis C Virus Infection
Journal: Current HIV Research
Volume: 7 Issue: 4 Year: 2009 Page: 447-455
Author(s): E. Angeli, A. Mainini, A. Cargnel, C. Uberti-Foppa, A. Orani, R. Carbone, M. Andreoni, M. Schiavini, R. Giorgi, G. Rizzardini, G. Gubertini
Liver-Related Factors Associated with Low Vitamin D Levels in HIV and HIV/HCV Coinfected Patients and Comparison to General Population
Journal: Current HIV Research
Volume: 9 Issue: 3 Year: 2011 Page: 186-193
Author(s): Laura Milazzo, Cristina Mazzali, Giovanna Bestetti, Erika Longhi, Antonella Foschi, Anita Viola, Tarcisio Vago, Massimo Galli, Carlo Parravicini, Spinello Antinori
How Current Direct-Acting Antiviral and Novel Cell Culture Systems for HCV are Shaping Therapy and Molecular Diagnosis of Chronic HCV Infection?
Journal: Current Drug Targets
Volume: 18 Issue: 7 Year: 2017 Page: 811-825
Author(s): Fabrizio Maggi,Daniele Focosi,Mauro Pistello
Impact of Dose Reduction on the Efficacy of Triple Therapy for Patients Infected with Genotype 1b and High Viral Loads
Ebook: Advances in Modern Medicine
Volume: 1 Year: 2017
Author(s): Hiroshi Kohno,Hirotaka Kouno,Toshiki Yamaguchi,Atsushi Yamaguchi,Toshio Kuwai
Doi: 10.2174/9781681080239117010032
Chronic Hepatitis C and Alcohol Abuse: The Single Center Experience of Novi Sad - Serbia
Journal: Reviews on Recent Clinical Trials
Volume: 11 Issue: 3 Year: 2016 Page: 208-212
Author(s): Tomislav Preveden,Maja Ruzic,Dajana Lendak,Maria Pete,Ludovico Abenavoli,Snezana Brkic
Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 9 Year: 2009 Page: 1115-1121
Author(s): I. Gentile, C. Viola, F. Borgia, G. Castaldo, G. Borgia
Population Pharmacokinetics and Pharmacodynamics of Albinterferon Alfa-2b in Patients Treated for Hepatitis C Virus Genotype 2/3
Journal: Anti-Infective Agents
Volume: 12 Issue: 1 Year: 2014 Page: 58-67
Author(s): Jing Yu,Haiying Sun,Maria Pang,Wan-Long Chuang,Shiv K. Sarin,Robert Flisiak,Daniel S. Stein
Antiangiogenic Agents: Studies on Fumagillin and Curcumin Analogs
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 3 Year: 2005 Page: 357-373
Author(s): M. S. Furness, T. P. Robinson, T. Ehlers, R. B. Hubbard IV, J. L. Arbiser, D. J. Goldsmith, J. P. Bowena
Current and Future Therapy for Chronic Hepatitis C Virus Liver Disease
Journal: Current Drug Targets - Infectious Disorders
Volume: 3 Issue: 3 Year: 2003 Page: 247-253
Author(s): G. Lake-Bakaar